BACKGROUND: The number of hypercholesterolemic individuals who do not meet their cholesterol recommended targets is inappropriately high. The use of plant sterol-enriched foods could help in this clinical setting. AIM OF THE STUDY: To evaluate the efficacy and side effects of plant sterol-enriched fermented milk in reducing LDL-cholesterol and increasing the number of patients who attain their therapeutic targets. METHODS: This was a multicentre, randomised, double-blind, placebo-controlled, parallel clinical trial. Eighty-three hypercholesterolemic patients that were not at therapeutic goals were studied. The patients received one 100 ml serving of either plain (control) low-fat or phytosterol enriched (1.6 g of free sterol equivalents) drinkable yogurt per day along with the main meal for 42 days. The principal variables were variation on LDL cholesterol (LDL-C) concentration and the number of patients achieving therapeutic goals after intervention. RESULTS: Patients on phytosterols attained an average LDL-C reduction of more than 10% (12.2% after 3 weeks; 10.6% after 6 weeks) (P = 0.001; 95% CI: 4.03-19.00) regardless of statin therapy compared to the control group. About 50% of the subjects on phytosterols, as compared to 20% of controls, attained their LDL-C target values (<3.3 or <2.6 mmol/l for primary and secondary prevention, respectively) at the end of the study (P < 0.001). HDL-cholesterol (HDL-C) did not change and triglycerides (TG) were decreased by 14% (P < 0.018). The plasma sterols/total cholesterol ratio increased. CONCLUSIONS:Plant sterol-enriched fermented milk significantly reduced LDL-C and increased the number of moderately hypercholesterolemic patients achieving therapeutic targets.
RCT Entities:
BACKGROUND: The number of hypercholesterolemic individuals who do not meet their cholesterol recommended targets is inappropriately high. The use of plant sterol-enriched foods could help in this clinical setting. AIM OF THE STUDY: To evaluate the efficacy and side effects of plant sterol-enriched fermented milk in reducing LDL-cholesterol and increasing the number of patients who attain their therapeutic targets. METHODS: This was a multicentre, randomised, double-blind, placebo-controlled, parallel clinical trial. Eighty-three hypercholesterolemicpatients that were not at therapeutic goals were studied. The patients received one 100 ml serving of either plain (control) low-fat or phytosterol enriched (1.6 g of free sterol equivalents) drinkable yogurt per day along with the main meal for 42 days. The principal variables were variation on LDL cholesterol (LDL-C) concentration and the number of patients achieving therapeutic goals after intervention. RESULTS:Patients on phytosterols attained an average LDL-C reduction of more than 10% (12.2% after 3 weeks; 10.6% after 6 weeks) (P = 0.001; 95% CI: 4.03-19.00) regardless of statin therapy compared to the control group. About 50% of the subjects on phytosterols, as compared to 20% of controls, attained their LDL-C target values (<3.3 or <2.6 mmol/l for primary and secondary prevention, respectively) at the end of the study (P < 0.001). HDL-cholesterol (HDL-C) did not change and triglycerides (TG) were decreased by 14% (P < 0.018). The plasma sterols/total cholesterol ratio increased. CONCLUSIONS: Plant sterol-enriched fermented milk significantly reduced LDL-C and increased the number of moderately hypercholesterolemicpatients achieving therapeutic targets.
Authors: Ramon Estruch; Miguel Angel Martínez-González; Dolores Corella; Jordi Salas-Salvadó; Valentina Ruiz-Gutiérrez; María Isabel Covas; Miguel Fiol; Enrique Gómez-Gracia; Mari Carmen López-Sabater; Ernest Vinyoles; Fernando Arós; Manuel Conde; Carlos Lahoz; José Lapetra; Guillermo Sáez; Emilio Ros Journal: Ann Intern Med Date: 2006-07-04 Impact factor: 25.391
Authors: R Korpela; J Tuomilehto; P Högström; L Seppo; V Piironen; P Salo-Väänänen; J Toivo; C Lamberg-Allardt; M Kärkkäinen; T Outila; J Sundvall; S Vilkkilä; M J Tikkanen Journal: Eur J Clin Nutr Date: 2006-05 Impact factor: 4.016
Authors: Boris Hansel; Catherine Nicolle; Florent Lalanne; Françoise Tondu; Taous Lassel; Yves Donazzolo; Jean Ferrières; Michel Krempf; Jean-Louis Schlienger; Bruno Verges; M John Chapman; Eric Bruckert Journal: Am J Clin Nutr Date: 2007-09 Impact factor: 7.045
Authors: J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard Journal: N Engl J Med Date: 1995-11-16 Impact factor: 91.245
Authors: Peter J H Jones; Maryam Shamloo; Dylan S MacKay; Todd C Rideout; Semone B Myrie; Jogchum Plat; Jean-Baptiste Roullet; David J Baer; Kara L Calkins; Harry R Davis; P Barton Duell; Henry Ginsberg; Helena Gylling; David Jenkins; Dieter Lütjohann; Mohammad Moghadasian; Robert A Moreau; David Mymin; Richard E Ostlund; Rouyanne T Ras; Javier Ochoa Reparaz; Elke A Trautwein; Stephen Turley; Tim Vanmierlo; Oliver Weingärtner Journal: Nutr Rev Date: 2018-10-01 Impact factor: 7.110
Authors: María J Soto-Méndez; Oscar D Rangel-Huerta; María D Ruiz-López; Emilio Martínez de Victoria; Augusto Anguita-Ruiz; Angel Gil Journal: Adv Nutr Date: 2019-05-01 Impact factor: 8.701
Authors: Isabelle Demonty; Rouyanne T Ras; Henk C M van der Knaap; Linsie Meijer; Peter L Zock; Johanna M Geleijnse; Elke A Trautwein Journal: Eur J Nutr Date: 2012-01-18 Impact factor: 5.614
Authors: Carla M Sá; Alice A Ramos; Marisa F Azevedo; Cristovao F Lima; Manuel Fernandes-Ferreira; Cristina Pereira-Wilson Journal: Int J Mol Sci Date: 2009-09-09 Impact factor: 6.208
Authors: Christina Weidner; Michel Krempf; Jean-Marie Bard; Murielle Cazaubiel; Doris Bell Journal: Lipids Health Dis Date: 2008-10-06 Impact factor: 3.876